CTOs on the Move

Pathalys

www.pathalys.com

 
Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pathalys.com
  • 4242 Six Forks Road Suite 820
    Raleigh, NC USA 27609
  • Phone: n/a

Executives

Name Title Contact Details
David Banks
 Senior Vice President of Technical Operations Profile

Similar Companies

Caldera Pharmaceuticals

Caldera Pharmaceuticals is a Los Alamos, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BeyondSpring

BeyondSpring is a Global, Clinical-Stage. Bio-pharmaceutical Company. Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform.

Grand Prairie Svcs

Regulatory Applications and Strategy Consulting

Regulatory Applications and Strategy Consulting is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Rib-X Pharmaceuticals

Rib-X Pharmaceuticals, Inc. is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.